Innovalve Bio Medical Ltd.

Innovalve Bio Medical Ltd. is a medical device company based in Ramat Gan, Israel. The company specializes in developing catheter-delivered heart valve therapies, focusing on transcatheter mitral valve replacement (TMVR) technologies. Innovalve is recognized as an innovator in TMVR, creating minimally invasive solutions for treating mitral valve disease, which is a complex structural heart condition. The company has developed a TMVR platform that has demonstrated promising early clinical results. This technology aims to provide alternatives to traditional open-heart surgery, allowing for valve replacement through catheter-based procedures, which can reduce patient risk and recovery time. Innovalve primarily serves healthcare providers and hospitals that specialize in cardiovascular care, particularly those focused on structural heart interventions. In July 2024, Innovalve Bio Medical was acquired by Edwards Lifesciences, a leader in heart valve therapies. This acquisition integrates Innovalve’s TMVR technologies into Edwards’ product offerings, enhancing their portfolio of transcatheter repair and replacement therapies for mitral and tricuspid valve diseases.

• Employees 27